Invert emulsion composition containing calcitriol and clobetasol 17-propionate, and uses thereof in cosmetics and dermatology

Details for Australian Patent Application No. 2005261570 (hide)

Owner Galderma S.A.

Inventors Orsoni, Sandrine; Zanutto, Leslie; Fredon, Laurent

Agent Griffith Hack

Pub. Number AU-A-2005261570

PCT Pub. Number WO2006/005843

Priority 0406612 17.06.04 FR

Filing date 15 June 2005

Wipo publication date 19 January 2006

International Classifications

A61K 31/593 (2006.01)

A61K 8/63 (2006.01) Cosmetics or similar toilet preparations

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61K 31/59 (2006.01) - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems

A61K 31/70 (2006.01) - Carbohydrates

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61Q 19/00 (2006.01) Preparations for care of the skin

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

Event Publications

18 January 2007 PCT application entered the National Phase

  PCT publication WO2006/005843 Priority application(s): WO2006/005843

23 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005261571-Pressurized foaming composition for topical treatment of psoriasis

2005261569-Pharmaceutical composition comprising an ointment and two solubilized active principles